Citadel Advisors’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
|
|||||
|
2025
Q1 | $1.61M | Sell |
|
|||||
|
2024
Q4 | $9.06M | Buy |
|
|||||
|
2024
Q3 | $2.66M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $476K | Sell |
|
|||||
|
2023
Q4 | $151K | Buy |
|
|||||
|
2023
Q3 | $54.8K | Sell |
|
|||||
|
2023
Q2 | $1.95M | Sell |
|
|||||
|
2023
Q1 | $7.26M | Buy |
|
|||||
|
2022
Q4 | $1.49M | Buy |
|
|||||
|
2022
Q3 | $2.45M | Buy |
|
|||||
|
2022
Q2 | $5.74M | Sell |
|
|||||
|
2022
Q1 | $10.6M | Sell |
|
|||||
|
2021
Q4 | $22.8M | Buy |
|
|||||
|
2021
Q3 | $29.2M | Buy |
|
|||||
|
2021
Q2 | $859K | Sell |
|
|||||
|
2021
Q1 | $969K | Buy |
|